Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 17 Sept 2026 for Tarsus Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleDavid e. I. Pyott
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
David e. I. Pyott: trading record in brief
David e. I. Pyott (board member) discloses dealings in 3 companies, chiefly Alnylam Pharmaceuticals, Inc., Biomarin Pharmaceutical Inc and Tarsus Pharmaceuticals, Inc. We count 19 filings; the first trade dates from 4 January 2016 and the latest from 15 September 2026.
Every open-market trade on record is a sale: 6 sales worth €3.0M. The rest of the record consists of 7 share grants and 6 option exercises. So far in 2026, the count stands at no purchases and 5 sales.
On 17 September 2026 came the latest disclosure, an option exercise in Tarsus Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David e. I. Pyott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
201 sharesCommon StockSEC:0001051578-26-000010:0
1,175 shares@ US$298.910.0011% mcap5.9% of flowCommon StockSEC:0001178670-26-000048:2
17 shares@ US$302.650.0000% mcap0.1% of flowCommon StockSEC:0001178670-26-000048:5
921 shares@ US$297.710.0008% mcap4.6% of flowCommon StockSEC:0001178670-26-000048:1
1,222 shares@ US$299.870.0011% mcap6.2% of flowCommon StockSEC:0001178670-26-000048:3
495 shares@ US$300.720.0005% mcap2.5% of flowCommon StockSEC:0001178670-26-000048:4
3,830 shares0Common StockSEC:0001178670-26-000048:0
671 shares0Common StockSEC:0001178670-26-000039:0
1,383 sharesCommon StockSEC:0001051578-26-000006:0
775 shares0Common StockSEC:0001735276-25-000063:0
7,440 shares@ US$299.0040.2% of flowCommon StockSEC:0001735276-25-000040:1
7,440 shares@ US$88.9512.0% of flowCommon StockSEC:0001735276-25-000040:0
17,560 shares@ US$88.9528.5% of flowCommon StockSEC:0001735276-24-000070:0
4,720 shares0Common StockSEC:0001048477-24-000110:0
4,190 shares0Common StockSEC:0001209191-23-031977:0
136 shares0Common StockSEC:0001735276-23-000018:0
4,980 shares0Common StockSEC:0001567619-22-011800:0
5,120 shares0Common StockSEC:0001567619-21-011320:0
2,100 sharesCommon StockSEC:0001140361-16-046894:0
19 of 19 declarations
